Segment Information (Schedule of Segment Information) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2015		Jun. 30, 2014		Jun. 30, 2015		Jun. 30, 2014		Dec. 31, 2014
Segment sales	$ 8,660		$ 9,783		$ 17,901		$ 19,992
Less: Transfers	65		77		134		158
Net sales	8,595		9,706		17,767		19,834
PTOI	1,637		1,955		3,578		4,203
Agriculture [Member]
Segment sales	3,218		3,615		7,155		8,009
Less: Transfers	0		5		0		8
Net sales	3,218		3,610		7,155		8,001
PTOI	774	[1]	789	[2]	1,948	[1],[3]	2,231	[2]
Segment net assets	10,246				10,246				$ 6,695
Increase in net assets					3,551
Electronics & Communications [Member]
Segment sales	534		617		1,055		1,197
Less: Transfers	6		4		10		7
Net sales	528		613		1,045		1,190
PTOI	104	[1]	21	[2]	189	[1]	96	[2]
Industrial Biosciences [Member]
Segment sales	288		317		573		618
Less: Transfers	3		4		8		7
Net sales	285		313		565		611
PTOI	49	[1]	57	[2]	105	[1]	113	[2]
Nutrition & Health [Member]
Segment sales	826		926		1,639		1,787
Less: Transfers	0		0		0		0
Net sales	826		926		1,639		1,787
PTOI	99	[1]	97	[2]	188	[1]	190	[2]
Performance Chemicals [Member]
Segment sales	1,502		1,696		2,866		3,287
Less: Transfers	28		48		57		105
Net sales	1,474		1,648		2,809		3,182
PTOI	54	[1],[4]	232	[2]	183	[1],[4]	438	[2]
Performance Materials [Member]
Segment sales	1,365		1,582		2,776		3,116
Less: Transfers	27		15		57		29
Net sales	1,338		1,567		2,719		3,087
PTOI	309	[1]	665	[2],[5]	636	[1]	958	[2],[5]
Safety & Protection [Member]
Segment sales	925		1,029		1,834		1,976
Less: Transfers	1		1		2		2
Net sales	924		1,028		1,832		1,974
PTOI	308	[1],[6]	178	[2]	492	[1],[6]	353	[2]
Gain related to litigation settlement					112
Other Segment [Member]
Segment sales	2		1		3		2
Less: Transfers	0		0		0		0
Net sales	2		1		3		2
PTOI	(60)		(84)	[2]	(163)	[7]	(176)	[2]
Imprelis [Member]
Insurance recoveries for litigation					35
Imprelis [Member] | Agriculture [Member]
Insurance recoveries for litigation					35
Cost basis investment impairment [Member]
Cost basis investment impairment					(37)
Cost basis investment impairment [Member] | Other Segment [Member]
Cost basis investment impairment					(37)
2014 Restructuring Program [Member]
Restructuring reserve, accrual adjustment					0
Restructuring charges			(263)				(206)
2014 Restructuring Program [Member] | Agriculture [Member]
Restructuring reserve, accrual adjustment	(4)				(4)
Restructuring charges			(47)				(47)
2014 Restructuring Program [Member] | Electronics & Communications [Member]
Restructuring reserve, accrual adjustment	11				11
Restructuring charges			(68)				(68)
2014 Restructuring Program [Member] | Industrial Biosciences [Member]
Restructuring reserve, accrual adjustment	(1)				(1)
Restructuring charges			(2)				(2)
2014 Restructuring Program [Member] | Nutrition & Health [Member]
Restructuring reserve, accrual adjustment	(4)				(4)
Restructuring charges			(8)				(8)
2014 Restructuring Program [Member] | Performance Chemicals [Member]
Restructuring reserve, accrual adjustment	2				2
Restructuring charges			(19)				(19)
2014 Restructuring Program [Member] | Performance Materials [Member]
Restructuring reserve, accrual adjustment	(2)				(2)
Restructuring charges			(29)				(29)
2014 Restructuring Program [Member] | Safety & Protection [Member]
Restructuring reserve, accrual adjustment	1				1
Restructuring charges			(31)				(31)
2014 Restructuring Program [Member] | Other Segment [Member]
Restructuring reserve, accrual adjustment	(3)				$ (3)
Restructuring charges			$ (2)				(2)
Chemours Restructuring Program [Member]
Restructuring charges	(61)
Chemours Restructuring Program [Member] | Performance Chemicals [Member]
Restructuring charges	$ (61)
GLS/Vinyls [Member]
Pre-tax gain							391
GLS/Vinyls [Member] | Performance Materials [Member]
Pre-tax gain							$ 391

[1] Included adjustments to the estimated costs associated with the 2014 restructuring program, recorded in employee separation / asset related charges, net. These adjustments were primarily due to lower than estimated individual severance costs and workforce reductions achieved through non-severance programs, partially offset by identification of additional projects in certain segments. There was no impact from these adjustments to the company's interim Consolidated Income Statements. The adjustments impacted segment results for the three months ended June 30, 2015 as follows: Agriculture - $(4) , Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Chemicals - $2, Performance Materials - $(2), and Safety & Protection $1, and Other - $(3). See Note 3 for additional information.

[2] Included a $(206) restructuring charge recorded in employee separation / asset related charges, net. The pre-tax charges by segment are: Agriculture - $(47) , Electronics & Communications - $(68) , Industrial Biosciences - $(2) , Nutrition & Health - $(8) , Performance Chemicals - $(19) , Performance Materials - $(29) , Safety & Protection - $(31), and Other - $(2). See Note 3 for additional information.

[3] Included $35 of insurance recoveries recorded in other operating charges for recovery of costs for customer claims related to the use of the Imprelis® herbicide. See Note 10 for additional information.

[4] Included a $(61) restructuring charge recorded in employee separation / asset related charges, net, consisting of severance and related benefit costs in the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-separation. See Note 3 for additional information.

[5] Included a gain of $391 recorded in other income, net associated with the sale of GLS/Vinyls. See Note 2 for additional information.

[6] Included a gain of $112, net of legal expenses, recorded in other income, net related to the company’s settlement of a legal claim.

[7] Included a $(37) pre-tax impairment charge recorded in employee separation / asset related charges, net for a cost basis investment. See Note 3 for additional information.